Humana Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $460.38
- Today's High:
- $472.39
- Open Price:
- $465.69
- 52W Low:
- $423.29
- 52W High:
- $568.2549
- Prev. Close:
- $467.18
- Volume:
- 808543
Company Statistics
- Market Cap.:
- $57.96 billion
- Book Value:
- 135.86
- Revenue TTM:
- $98.73 billion
- Operating Margin TTM:
- 4.87%
- Gross Profit TTM:
- $17.18 billion
- Profit Margin:
- 3.42%
- Return on Assets TTM:
- 5.82%
- Return on Equity TTM:
- 20.8%
Company Profile
Humana Inc had its IPO on 1993-01-22 under the ticker symbol HUM.
The company operates in the Healthcare sector and Healthcare Plans industry. Humana Inc has a staff strength of 67,100 employees.
Stock update
Shares of Humana Inc opened at $465.69 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $460.38 - $472.39, and closed at $469.07.
This is a +0.4% increase from the previous day's closing price.
A total volume of 808,543 shares were traded at the close of the day’s session.
In the last one week, shares of Humana Inc have increased by +1.84%.
Humana Inc's Key Ratios
Humana Inc has a market cap of $57.96 billion, indicating a price to book ratio of 4.1547 and a price to sales ratio of 0.7036.
In the last 12-months Humana Inc’s revenue was $98.73 billion with a gross profit of $17.18 billion and an EBITDA of $5.16 billion. The EBITDA ratio measures Humana Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Humana Inc’s operating margin was 4.87% while its return on assets stood at 5.82% with a return of equity of 20.8%.
In Q2, Humana Inc’s quarterly earnings growth was a positive 39.8% while revenue growth was a positive 13%.
Humana Inc’s PE and PEG Ratio
- Forward PE
- 18.6567
- Trailing PE
- 17.4201
- PEG
- 1.283
Its diluted EPS in the last 12-months stands at $26.85 per share while it has a forward price to earnings multiple of 18.6567 and a PEG multiple of 1.283. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Humana Inc’s profitability.
Humana Inc stock is trading at a EV to sales ratio of 0.7084 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.7036.
Humana Inc stock pays annual dividends of $3.345 per share, indicating a yield of 0.76% and a payout ratio of 12.84%.
Balance sheet and cash flow metrics
- Total Assets
- $56.46 billion
- Total Liabilities
- $28.28 billion
- Operating Cash Flow
- $-733000000.00
- Capital Expenditure
- $264 million
- Dividend Payout Ratio
- 12.84%
Humana Inc ended 2024 with $56.46 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $56.46 billion while shareholder equity stood at $16.83 billion.
Humana Inc ended 2024 with $0 in deferred long-term liabilities, $28.28 billion in other current liabilities, 33000000.00 in common stock, $27.47 billion in retained earnings and $9.54 billion in goodwill. Its cash balance stood at $16.21 billion and cash and short-term investments were $31.47 billion. The company’s total short-term debt was $2,479,000,000 while long-term debt stood at $9.72 billion.
Humana Inc’s total current assets stands at $38.76 billion while long-term investments were $16.37 billion and short-term investments were $15.25 billion. Its net receivables were $1.43 billion compared to accounts payable of $18.42 billion and inventory worth $0.
In 2024, Humana Inc's operating cash flow was $-733000000.00 while its capital expenditure stood at $264 million.
Comparatively, Humana Inc paid $0.13 in dividends in 2024.
Other key metrics
- Current Trading Price
- $469.07
- 52-Week High
- $568.2549
- 52-Week Low
- $423.29
- Analyst Target Price
- $584.41
Humana Inc stock is currently trading at $469.07 per share. It touched a 52-week high of $568.2549 and a 52-week low of $568.2549. Analysts tracking the stock have a 12-month average target price of $584.41.
Its 50-day moving average was $466.03 and 200-day moving average was $493.07 The short ratio stood at 1.81 indicating a short percent outstanding of 0%.
Around 16.8% of the company’s stock are held by insiders while 9563.5% are held by institutions.
Frequently Asked Questions About Humana Inc
Similar Industry Stocks (Healthcare Plans)
Most Active
Top Gainers
Top Losers
About
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.